Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  Google Scholar 

Zhang W, et al. Global, regional and national incidence, mortality and disability-adjusted life-years of skin cancers and trend analysis from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019. Cancer Med. 2021;10(14):4905–22.

Article  Google Scholar 

Staples MP, et al. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006;184(1):6–10.

Article  Google Scholar 

Tokez S, et al. Incidence of multiple vs first cutaneous squamous cell carcinoma on a nationwide scale and estimation of future incidences of cutaneous squamous cell carcinoma. JAMA Dermatol. 2020;156(12):1300–6.

Article  Google Scholar 

Olsen CM, et al. Keratinocyte cancer incidence in Australia: a review of population-based incidence trends and estimates of lifetime risk. Public Health Res Pract. 2022;32(1):3212203.

Article  Google Scholar 

Perera E, et al. Incidence and prevalence of non-melanoma skin cancer in Australia: a systematic review. Australas J Dermatol. 2015;56(4):258–67.

Article  Google Scholar 

GBD Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459–544.

Article  Google Scholar 

Stang A, et al. Incidence and mortality for cutaneous squamous cell carcinoma: comparison across three continents. J Eur Acad Dermatol Venereol. 2019;33(Suppl 8):6–10.

Article  Google Scholar 

Subramaniam P, et al. Anatomical distributions of basal cell carcinoma and squamous cell carcinoma in a population-based study in Queensland, Australia. JAMA Dermatol. 2017;153(2):175–82.

Article  Google Scholar 

Thompson AK, et al. Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis. JAMA Dermatol. 2016;152(4):419–28.

Article  Google Scholar 

Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992;26(6):976–90.

Article  CAS  Google Scholar 

Lansbury L, et al. Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies. BMJ. 2013;347: f6153.

Article  Google Scholar 

Moreno-Ramírez D, et al. Surgery for cutaneous squamous cell carcinoma and its limits in advanced disease. Dermatol Pract Concept. 2021;11(Suppl 2):e2021167S.

Article  Google Scholar 

Lubov J, et al. Prognostic factors of head and neck cutaneous squamous cell carcinoma: a systematic review. J Otolaryngol Head Neck Surg. 2021;50(1):54.

Article  Google Scholar 

Migden MR, et al. PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma. N Engl J Med. 2018;379(4):341–51.

Article  CAS  Google Scholar 

Maubec E, et al. Phase II study of pembrolizumab as first-line, single-drug therapy for patients with unresectable cutaneous squamous cell carcinomas. J Clin Oncol. 2020;38(26):3051–61.

Article  Google Scholar 

McLean LS, et al. Immunotherapy to avoid orbital exenteration in patients with cutaneous squamous cell carcinoma. Front Oncol. 2022;11:796197–796197.

Article  Google Scholar 

Edwards MJ, et al. Squamous cell carcinoma arising in previously burned or irradiated skin. Arch Surg. 1989;124(1):115–7.

Article  CAS  Google Scholar 

Tam S, et al. Association of immunosuppression with outcomes of patients with cutaneous squamous cell carcinoma of the head and neck. JAMA Otolaryngol Head Neck Surg. 2020;146(2):128–35.

Article  Google Scholar 

Fogel AL, Sarin KY, Teng JMC. Genetic diseases associated with an increased risk of skin cancer development in childhood. Curr Opin Pediatr. 2017;29(4):426–33.

Article  Google Scholar 

Qureshi AA, et al. Geographic variation and risk of skin cancer in US women. Differences between melanoma, squamous cell carcinoma, and basal cell carcinoma. Arch Intern Med. 2008;168(5):501–7.

Article  Google Scholar 

Zanetti R, et al. Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case-control study. Br J Cancer. 2006;94(5):743–51.

Article  CAS  Google Scholar 

Moan J, et al. The relationship between UV exposure and incidence of skin cancer. Photodermatol Photoimmunol Photomed. 2015;31(1):26–35.

Article  Google Scholar 

Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B. 2001;63(1–3):8–18.

Article  CAS  Google Scholar 

Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124(6):869–71.

Article  CAS  Google Scholar 

Weinstock MA. Assessment of sun sensitivity by questionnaire: validity of items and formulation of a prediction rule. J Clin Epidemiol. 1992;45(5):547–52.

Article  CAS  Google Scholar 

Koh D, et al. Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore Cancer Registry data 1968–97. Br J Dermatol. 2003;148(6):1161–6.

Article  CAS  Google Scholar 

Gloster HM Jr, Neal K. Skin cancer in skin of color. J Am Acad Dermatol. 2006;55(5):741–60 (quiz 761–4).

Article  Google Scholar 

Halder RM, Bang KM. Skin cancer in blacks in the United States. Dermatol Clin. 1988;6(3):397–405.

Article  CAS  Google Scholar 

Mora RG, Perniciaro C. Cancer of the skin in blacks. I. A review of 163 black patients with cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1981;5(5):535–43.

Article  CAS  Google Scholar 

Scotto J, Fears TR, Fraumeni JF. Incidence of nonmelanoma skin cancer in the United States (1983).

Brenner M, Hearing VJ. The protective role of melanin against UV damage in human skin. Photochem Photobiol. 2008;84(3):539–49.

Article  CAS  Google Scholar 

Gogia R, et al. Fitzpatrick skin phototype is an independent predictor of squamous cell carcinoma risk after solid organ transplantation. J Am Acad Dermatol. 2013;68(4):585–91.

Article  Google Scholar 

Hartevelt MM, et al. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation. 1990;49(3):506–9.

Article  CAS  Google Scholar 

Jensen P, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol. 1999;40(2 Pt 1):177–86.

Article  CAS  Google Scholar 

Lindelof B, et al. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol. 2000;143(3):513–9.

CAS  Google Scholar 

Bouwes Bavinck JN, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation. 1996;61(5):715–21.

Article  CAS  Google Scholar 

Jiyad Z, et al. Azathioprine and risk of skin cancer in organ transplant recipients: systematic review and meta-analysis. Am J Transplant. 2016;16(12):3490–503.

Article  CAS  Google Scholar 

Inman GJ, et al. The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature. Nat Commun. 2018;9(1):3667.

Article  Google Scholar 

Harwood CA, et al. PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients. Br J Cancer. 2008;99(8):1276–84.

Article  CAS  Google Scholar 

O’Donovan P, et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science. 2005;309(5742):1871–4.

Article  CAS  Google Scholar 

Adamson R, et al. High incidence and clinical course of aggressive skin cancer in heart transplant patients: a single-center study. Transplant Proc. 1998;30(4):1124–6.

Article  CAS  Google Scholar 

Euvrard S, et al. Aggressive squamous cell carcinomas in organ transplant recipients. Transplant Proc. 1995;27(2):1767–8.

CAS  Google Scholar 

Veness MJ, et al. Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience. Cancer. 1999;85(8):1758–64.

Article  CAS  Google Scholar 

Winkelhorst JT, et al. Incidence and clinical course of de-novo malignancies in renal allograft recipients. Eur J Surg Oncol. 2001;27(4):409–13.

Article  CAS  Google Scholar 

Martinez JC, et al. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. Arch Dermatol. 2003;139(3):301–6.

Article  Google Scholar 

Levi F, et al. Non-Hodgkin’s lymphomas, chronic lymphocytic leukaemias and skin cancers. Br J Cancer. 1996;74(11):1847–50.

Article  CAS  Google Scholar 

Tsiodras S, et al. Infection and immunity in chronic lymphocytic leukemia. Mayo Clin Proc. 2000;75(10):1039–54.

Article  CAS  Google Scholar 

Cantwell M, et al. Acquired CD40-ligand deficiency in chronic lymphocytic leukemia. Nat Med. 1997;3(9):984–9.

Article  CAS  Google Scholar 

Lindqvist CA, et al. T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malig